Shapouri S, Candrilli S, Miles L, Simpson A, Guittari CJ. Real-world treatment with risdiplam in adults with SMA: a multicenter study. Poster presented at the 2023 Annual SMA Research & Clinical Care Meeting; June 28, 2023. Orlando, FL.
Rajagopalan K, Candrilli SD, Ajmera M. Impact of antiepileptic drug-treatment burden on health-care-resource utilization and costs. Clinicoecon Outcomes Res. 2018 Oct 16;2018(10):619-27. doi: 10.2147/CEOR.S180913
Bell C, Kurosky SK, Candrilli SD. Muscular dystrophy-related hospitalizations among male pediatric patients in the United States. Hospital Practice. 2015 Aug;43(3):180-5.
Meyers J, Candrilli S, Allen R, Manjunath R, Calloway M. Health care resource utilization and costs associated with restless legs syndrome among managed care enrollees treated with dopamine agonists. Manag Care. 2012 Oct 1;21(10):44-51.
Meyers J, Candrilli SD. Patient characteristics and charges associated with emergency department visits among patients with a diagnosis of restless legs syndrome. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A390.
Candrilli SD, Manjunath R, Davis KL, Gidal BE. The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy. Epilepsy Res. 2010 Oct 1;91(2-3):260-6.
Ettinger AB, Manjunath R, Candrilli SD, Davis KL. Prevalence and cost of nonadherence with antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav. 2009 Feb;14(2):324-9. doi: 10.1016/j.yebeh.2008.10.021.
Manjunath RY, Davis KL, Candrilli SD, Ettinger AE. Association of antiepileptic drug nonadherence with risk of seizures in adults with epilepsy. Epilepsy Behav. 2009 Jan;14(2):372-8.
Gidal BE, Candrilli SD, Davis KL, Manjunath R. The association between antiepileptic drug and hmg-coa reductase inhibitor interactions and health outcomes in epilepsy. Poster presented at the 62nd Annual Meeting of the American Epilepsy Society; December 2008.
Davis KL, Candrilli SD, Edin HM. Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population. Epilepsia. 2008 Mar 1;49(3):446-54.
Ettinger AE, Candrilli SD, Davis KL, Manjunath R. Prevalence and cost impact of noncompliance with antiepileptic drugs in an elderly managed care population. Poster presented at the 61st Annual Meeting of the American Epilepsy Society; December 2007.
Davis KL, Manjunath R, Candrilli SD, Ettinger AB. Impact of compliance with antiepileptic drugs on risk of serious breakthrough seizure in an adult managed care population with epilepsy. Poster presented at the 61st Annual Meeting of the American Epilepsy Society; December 2007.
Davis KL, Candrilli SD, Manjunath R. Adherence with antiepileptic drugs and associated impact on time to seizure in adolescents diagnosed with epilepsy. Poster presented at the Annual Meeting of the Child Neurology Society; October 2007.
Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications. 2007 Oct 1;21(5):306-14.
Davis KL, Candrilli SD, Edin HM. Prevalence and cost impact of nonadherence with antiepilepsy drugs among adults in a managed care population. Poster presented at the Academy of Managed Care Pharmacy 19th Annual Meeting Showcase; April 14, 2007.
Davis KL, Candrilli SD, Kan HJ, Lucero MA, Covington MT. Estimating the effect of symptoms of diabetic peripheral neuropathy and diabetic retinopathy on quality-of-life using data from the 2001-2002 national health and nutrition examination survey. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):365.
Davis KL, Candrilli SD, Kan H, Lucero MA, Covington M. Estimating the effects of diabetic peripheral neuropathy and diabetic retinopathy on quality-of-life using data from the 2001-2002 national health and nutrition examination survey. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):365.
Candrilli SD, Davis KL, Kan H, Lucero MA, Covington M. Burden of illness associated with symptoms of diabetic peripheral neuropathy and diabetic retinopathy. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):357.
Hauber BHIV, Candrilli SD, Snyder EG, McBurney CR. Validation of a model to assess long-term disease progression in alzheimer's disease patients treated with rivastigmine. Poster presented at the 9th International Conference on Alzheimer's Disease and Related Disorders; July 2004.
Hauber B, Candrilli S, Snyder EH, McBurney CR. Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiol Aging. 2004 Jan 1;25:S136.